Weekly Recap: 12 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition and a groundbreaking surgical nerve treatment for veterans.

NEW YORK, July 25, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

    1. Waystar to Acquire Iodine Software, Accelerating the AI-Powered
       Transformation of Healthcare PaymentsWaystar brings a decade-long track
       record of applying AI pervasively across its software platform to
       simplify healthcare payments. Iodine extends that leadership into
       clinical intelligence software, leveraging proprietary AI models trained
       on one of the industry's largest clinical datasets, representing more
       than a third of all U.S. inpatient discharges.

    2. Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for
       US$1.6 billion"Vicebio and its incredibly passionate team have been
       driven by the ambition to develop next-generation vaccines aimed at
       targeting multiple life-threatening respiratory viruses simultaneously.
       This acquisition validates our ability to combine innovation and deep
       scientific expertise towards a common goal of advancing public health
       prevention," said Dr. Emmanuel Hanon, Chief Executive Officer of Vicebio.

    3. Former Sandoz Inc. CEO Don DeGolyer Leads PharmaTech Startup Ategenos as
       Company Prepares Public Launch Ategenos has been quietly developing a
       novel platform that integrates pharmaceutical science with real-time
       digital health technologies to address adherence in critical dose
       management. The company will share details on its SmartPatch platform and
       initial partnerships in the coming weeks.

    4. Cambridge Innovation Institute Announces Acquisition of Integrative
       Healthcare Symposium and Integrative Practitioner from Diversified "CII
       has been a leader in life science conferences for over three decades, and
       we are excited to add this new conference and publication covering other
       essential aspects of healthcare to our expanding CHI portfolio. The many
       facets of holistic medicine are growingly important within healthcare and
       will benefit from additional advancement via opportunities for knowledge
       sharing and collaboration," said Benjamin Lakin, PhD, CEO of Cambridge
       Innovation Institute.
    5. Answer ALS Launches AI Drug Development Collaboration with GATC Health,
       Pennington Biomedical Research Center, and Tulane to Advance ALS
       Treatment Discovery At the center of this effort is Dr. Jeffrey Keller of
       Pennington Biomedical, working in close partnership with Dr. Aron Culotta
       of Tulane. Together, they will lead a coordinated statewide effort of
       connecting researchers with expertise in AI, drug discovery,
       neuroscience, and clinical care, while all working together to drive
       innovation toward ALS treatments.

    6. Tulavi and VHSS Partner to Bring Groundbreaking Surgical Nerve Treatment
       to Veterans Impacted by Amputations and Traumatic Injuries The allay(TM)
       Hydrogel Cap is a novel, fully absorbable, and entirely sutureless
       medical device that provides a perfectly conforming and protective
       barrier to the injured nerve, supporting nerve recovery while reducing
       the risk of neuroma formation. Once deployed, the hydrogel cap remains in
       place for approximately eight months, protecting the nerve and blocking
       axonal escape during the critical period of neuroma formation.

    7. Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to
       revolutionize treatment paradigm for adults and adolescents with plaque
       psoriasis "The rapid patient enrollment across our ICONIC clinical
       program underscores the unmet need for an advanced plaque psoriasis
       treatment that meaningfully addresses their needs and preferences," said
       Liza O'Dowd, MD, Vice President, Immunodermatology and Respiratory
       Disease Area Lead, Johnson & Johnson Innovative Medicine.

    8. New Non-Invasive Glaucoma Treatment Offered for First Time in U.S.
       Eyetronic therapy provides external neural stimulation to the optic nerve
       of patients suffering from glaucoma, a disease in which the optic nerve
       is permanently damaged resulting in vision loss. Glaucoma is the leading
       cause of irreversible blindness in the world, affecting over 4 million
       people in the U.S. and more than 80 million people worldwide.

    9. Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's
       Gene Therapy Assets "KLTO hopes to work with AAVnerGene for manufacturing
       several of our product candidates composed of a tissue-specific promoter
       driving our Klotho gene to produce the Klotho protein and elevated
       concentrations of the protein in specific, targeted tissues and organs
       affected by these neurologic and neuromuscular diseases," said Dr. Joseph
       Sinkule, the CEO of KLTO.

    10. Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a
        New Ecosystem for Health Management By leveraging Novo Nordisk's
        expertise and innovative products in diabetes and obesity treatment,
        Fangzhou plans to employ its smart healthcare ecosystem and robust
        technology infrastructure to create a comprehensive health management
        service. This will include medication guidance, reminders, efficacy
        tracking, and health education, effectively shaping the value chain in
        the glucose control and weight loss sector.

    11. Avidity Biosciences Receives FDA Breakthrough Therapy Designation for
        Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People
        with Mutations Amenable to Exon 44 Skipping DMD is a rare genetic
        condition that is characterized by progressive muscle damage and
        weakness due to the loss of dystrophin protein that typically starts at
        a very young age. Del-zota is designed to deliver phosphorodiamidate
        morpholino oligomers (PMOs) to skeletal muscle and heart tissue to
        specifically skip exon 44 of the dystrophin gene and enable production
        of near-full length dystrophin.

    12. Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in
        Preclinical Study Results showed that a single dose administered by
        either intranasal (IN) or intramuscular (IM) routes induced neutralizing
        antibody responses (IN: 1:54; IM: 1:1,160), at or above the 1:40 titer
        generally considered to be a protective antibody response. The data
        showed even higher levels of immunity after two doses.

For more news like this, check out all of the latest health-related releases from PR Newswire.

Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

    --  Customization: Users can create customized newsfeeds that will deliver
        relevant news right to their inbox. Newsfeed results can be targeted by
        keywords, industry, subject, geography, and more.
    --  Photos and Videos: Thousands of multimedia assets are available to
        download and include in a journalist or blogger's next story.
    --  Subject Matter Experts: Journalists will have access to ProfNet, a
        database of industry experts to connect with as sources or for quotes in
        their articles.
    --  Related Resources: Our journalist- and blogger-focused blog, Beyond
        Bylines, features regular media news roundups, writing tips, upcoming
        events, and more.

About PR Newswire

PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at media.relations@cision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/weekly-recap-12-health-press-releases-you-need-to-see-302513571.html

SOURCE PR Newswire